MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Vistagen Therapeutics, Inc. (VTGN)
Vistagen Therapeutics, Inc. (VTGN)
source: myfinsight.com
Comprehensive loss
-$69,692K
(-35.55%↓ Y/Y)
Net loss
-$69,685K
(-35.53%↓ Y/Y)
Unrealized gain (loss) on
marketable securities
-$7K
(-240.00%↓ Y/Y)
Loss before income
taxes
-$69,678K
(-35.53%↓ Y/Y)
Income taxes
$7K
(0.00%↑ Y/Y)
Interest income, net
$2,441K
(-46.43%↓ Y/Y)
Other income, net
$7K
(40.00%↑ Y/Y)
Loss from operations
-$72,126K
(-28.86%↓ Y/Y)
Total revenues
$1,269K
(161.11%↑ Y/Y)
Total operating
expenses
$73,395K
(30.00%↑ Y/Y)
Research and development
$54,974K
(39.62%↑ Y/Y)
General and
administrative
$18,421K
(7.83%↑ Y/Y)
Back